13811-0705-50 — Sod Benzoate/ Sod Phenylacetate (ammonul) 10-10 % Soln 50 Ml Vial
Cite this view
HANK Price Transparency. (n.d.). sod benzoate/ sod phenylacetate (AMMONUL) 10-10 % Soln 50 mL Vial (NDC 13811-0705-50) negotiated rates. PPMan price-transparency data, derived from CMS-required hospital MRFs. Retrieved , from http://ppman.hank.ai/transparency/code/13811-0705-50?code_type=NDC
“sod benzoate/ sod phenylacetate (AMMONUL) 10-10 % Soln 50 mL Vial (NDC 13811-0705-50) negotiated rates.” HANK Price Transparency, http://ppman.hank.ai/transparency/code/13811-0705-50?code_type=NDC. Accessed .
“sod benzoate/ sod phenylacetate (AMMONUL) 10-10 % Soln 50 mL Vial (NDC 13811-0705-50) negotiated rates,” HANK Price Transparency, accessed , http://ppman.hank.ai/transparency/code/13811-0705-50?code_type=NDC.
Source: PPMan price-transparency data, derived from CMS-required hospital machine-readable files (45 CFR 180). See methodology.
Usually $91,070–$274,662 (25th–75th percentile) across 1 hospital · 7 payers.
“Negotiated” is the hospital’s negotiated facility rate for this NDC 13811-0705-50 — the consumer-grade median across the country. It covers the facility charge only; the surgeon’s and anesthesiologist’s fees are billed separately.
Per-month price trends are temporarily unavailable while we rebuild them on quality-filtered rates. The medians, percentiles, and per-hospital rates on this page are the quality-filtered figures.
Hospital rates (per row)
Showing consumer-grade rates only. Flagged / outlier filings (excluded from the medians above) are hidden — tick “Show flagged / outlier rates” to include them.
| Hospital | Payer | Plan | Negotiated rate | Gross | Cash | Observed | Source |
|---|---|---|---|---|---|---|---|
| GEISINGER SOUTH WILKES-BARRE Outpatient | Blue Cross Blue Shield | Highmark - Special Care | $63,486.28 | $392,375.00 | $243,272.50 | 2026-04-01 | MRF ↗ |
| GEISINGER SOUTH WILKES-BARRE Outpatient | Blue Cross Blue Shield | Capital - Special Network Rates | $63,760.94 | $392,375.00 | $243,272.50 | 2026-04-01 | MRF ↗ |
| GEISINGER SOUTH WILKES-BARRE Outpatient | Blue Cross Blue Shield | Highmark | $90,677.86 | $392,375.00 | $243,272.50 | 2026-04-01 | MRF ↗ |
| GEISINGER SOUTH WILKES-BARRE Outpatient | Blue Cross Blue Shield | Capital - Enhanced Network Rates | $91,070.24 | $392,375.00 | $243,272.50 | 2026-04-01 | MRF ↗ |
| GEISINGER SOUTH WILKES-BARRE Outpatient | Cigna | Cigna | $169,898.38 | $392,375.00 | $243,272.50 | 2026-04-01 | MRF ↗ |
| GEISINGER SOUTH WILKES-BARRE Inpatient | Cigna | Cigna | $177,745.88 | $392,375.00 | $243,272.50 | 2026-04-01 | MRF ↗ |
| GEISINGER SOUTH WILKES-BARRE Outpatient | Aetna | Aetna | $182,689.80 | $392,375.00 | $243,272.50 | 2026-04-01 | MRF ↗ |
| GEISINGER SOUTH WILKES-BARRE Inpatient | Christian Healthcare Ministries | Christian Healthcare Ministries | $196,187.50 | $392,375.00 | $243,272.50 | 2026-04-01 | MRF ↗ |
| GEISINGER SOUTH WILKES-BARRE Inpatient | Aetna | First Health Network | $262,106.50 | $392,375.00 | $243,272.50 | 2026-04-01 | MRF ↗ |
| GEISINGER SOUTH WILKES-BARRE Outpatient | Wyoming Seminary | Wyoming Seminary | $274,662.50 | $392,375.00 | $243,272.50 | 2026-04-01 | MRF ↗ |
| GEISINGER SOUTH WILKES-BARRE Inpatient | Multiplan | Multiplan/Private Health Care System | $333,518.75 | $392,375.00 | $243,272.50 | 2026-04-01 | MRF ↗ |
| GEISINGER SOUTH WILKES-BARRE Outpatient | Multiplan | Beech Street | $333,518.75 | $392,375.00 | $243,272.50 | 2026-04-01 | MRF ↗ |
| GEISINGER SOUTH WILKES-BARRE Outpatient | Intergroup Services | Intergroup Services | $333,518.75 | $392,375.00 | $243,272.50 | 2026-04-01 | MRF ↗ |